GNH USA

Europe — EMA

Noxap (Nitric Oxide)

Nitric Oxide, the active ingredient in Noxap, is a gasotransmitter presented as a pulmonary vasodilator for inhalation use. It treats pulmonary hypertension and related vascular conditions in adult patients.

Request sourcing

1
Pack/s

What is Nitric Oxide?

Nitric Oxide, the active ingredient in Noxap, is a gasotransmitter presented as a pulmonary vasodilator for inhalation use. It treats pulmonary hypertension and related vascular conditions in adult patients. GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Nitric Oxide used for?

Noxap is a pulmonary vasodilator that acts on the nitric oxide signaling pathway to improve vascular tone in the respiratory system.

- Pulmonary arterial hypertension: reduces vascular resistance  - Acute right‑ventricular failure : supports hemodynamic stability  - Post‑operative cardiopulmonary recovery : aids  as           t                 t t  t  t t t t t t t t t t t t t t t t t t t t t t t t t

What are the side effects of Nitric Oxide?

Common   g  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nitric Oxide
Route
Inhalation Use
Manufacturer
Air Products Sp. Z.O.O.
Origin
EU

Related products